DGAP-News

MeVis Medical Solutions AG: MeVis publishes final figures for fiscal year 2013 / Shares in Medis sold in April 2014

DGAP-News: MeVis Medical Solutions AG / Key word(s): Final Results
MeVis Medical Solutions AG: MeVis publishes final figures for fiscal
year 2013 / Shares in Medis sold in April 2014

24.04.2014 / 07:30

---------------------------------------------------------------------

2013 strongest year since IPO in 2007

- Group revenues increased by 10 % year on year to EUR 14.6 m

- Earnings before interest and taxes (EBIT) increased significantly by
EUR 1.0 m to EUR 4,0 m

- Net income of EUR 3.7 m (previous year EUR 2.2 m)

- Earnings per share increased from EUR 1.26 to EUR 2.14

- Liquidity increased by EUR 5.3 m to EUR 14.0 m (Dec.31, 2012: EUR 8.7
m)

- Sale of 41 % share in Medis in April 2014 at carrying value

Bremen, April 24, 2014 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a
leading provider of medical imaging software, today announced its final
figures for fiscal year 2013, which correspond to the preliminary figures
released on March 5, 2014.

The group revenues generated in 2013 amounted to EUR 14.6 m, up 10 %
compared to the previous year's revenues of EUR 13.3 m. The increase in
licensing business by 9 % from EUR 7.0 m to EUR 7.6 m as well as an
increase in non-recurring engineering contributions of EUR 0.5 m to EUR 0.8
m contributed to this growth. Maintenance revenues grew by 4 % to EUR 6.2
m.

The increase in revenues resulted almost entirely from the Digital
Mammography segment, where revenues rose from EUR 10.1 m to EUR 11.3 m,
while revenues in the Other Diagnostics segment grew only marginally from
EUR 3.2 m to EUR 3.3 m.

Operating costs could be reduced again in 2013 as staff costs decreased by
EUR 0.2 m from EUR 8.1 m to EUR 7.9 m and other operating expenses by as
much as EUR 0.4 m from EUR 2.3 m to EUR 1.9 m.

In 2013 the capitalization of development costs has been cut nearly in half
by EUR 1.0 m from EUR 2.4 m to EUR 1.4 m. This effect is almost entirely
offset by a decrease in depreciation of EUR 0.9 m from EUR 3.0 m to EUR 2.1
m.

For 2013 this results in an EBIT (earnings before interest and taxes) of
EUR 4.0 m, which is EUR 1.0 m higher than previous year and corresponds to
an EBIT margin of 28 % (previous year: 22 %).

After an improved financial result of EUR -0.2 m (previous year: EUR -0.6
m) and a low tax expense of EUR 0.1 m (previous year: EUR 0.2 m) the
consolidated net result came to EUR 3.7 m (previous year: EUR 2.2 m), which
corresponds to earnings per share of EUR 2.14 (previous year: EUR 1.26).

Cash and cash equivalents increased significantly in 2013 and amounted to